+3,722.6%
PANW vs GSK
+108.4%
+3,614.2%
-48.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.0% | -1.0% | +2.1% | +1.3% |
| 7D | +2.0% | -5.4% | +7.4% | +3.4% |
| 30D | -11.8% | -4.6% | -7.2% | -10.9% |
| 3M | +28.6% | -5.1% | +33.7% | +29.8% |
| 6M | +104.4% | -11.4% | +115.9% | +109.4% |
| YTD | +83.8% | +0.7% | +83.0% | +79.7% |
| 1Y | +71.5% | +23.0% | +48.5% | +56.4% |
| 3Y | +172.2% | +48.0% | +124.2% | +126.7% |
| 5Y | +332.2% | +48.2% | +284.0% | +251.3% |
| 10Y | +1,306.4% | +80.0% | +1,226.3% | +908.9% |
| All | +3,722.6% | +108.4% | +3,614.2% | +2,628.0% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling